Hertenstein B - Search Results

1

Emergence of CD52-, phosphatidylinositolglycan-anchor-deficient T lymphocytes after in vivo application of Campath-1H for refractory B-cell non-Hodgkin lymphoma.

Hertenstein B, Wagner B, Bunjes D, Duncker C, Raghavachar A, Arnold R, Heimpel H, Schrezenmeier H. Hertenstein B, et al. Blood. 1995 Aug 15;86(4):1487-92. Blood. 1995. PMID: 7632956 Free article. Clinical Trial.

2

ABO-incompatible bone marrow transplantation.

Wiesneth M, Hertenstein B, Bunjes D, Schmeiser T, Maccari B, Northoff H, Laasch H, Heit W, Arnold R, Heimpel H, et al. Wiesneth M, et al. Among authors: hertenstein b. Beitr Infusionsther. 1992;30:354-8. Beitr Infusionsther. 1992. PMID: 1284733

3

[Phases in the rehabilitation of male and female bone marrow transplant patients].

Arnold R, Bergerhoff P, Denzinger R, Hertenstein B, Kächele H, Novak P, Schwilk C, Simons C. Arnold R, et al. Among authors: hertenstein b. Psychother Psychosom Med Psychol. 1992 Jun;42(6):191-9; discussion 199-200. Psychother Psychosom Med Psychol. 1992. PMID: 1494634 German.

4

Thrombotic thrombocytopenic purpura in early pregnancy with maternal and fetal survival.

Rozdzinski E, Hertenstein B, Schmeiser T, Seifried E, Kurrle E, Heimpel H. Rozdzinski E, et al. Among authors: hertenstein b. Ann Hematol. 1992 May;64(5):245-8. doi: 10.1007/BF01738304. Ann Hematol. 1992. PMID: 1623060

5

Parvovirus B19 infection and bone marrow transplantation.

Frickhofen N, Arnold R, Hertenstein B, Wiesneth M, Young NS. Frickhofen N, et al. Among authors: hertenstein b. Ann Hematol. 1992 Jun;64 Suppl:A121-4. doi: 10.1007/BF01715363. Ann Hematol. 1992. PMID: 1637889 Review.

6

Graft failure after T cell-depleted bone marrow transplantation: clinical and immunological characteristics and response to immunosuppressive therapy.

Bunjes D, Wiesneth M, Hertenstein B, Schmeiser T, Arnold R, Heit W. Bunjes D, et al. Among authors: hertenstein b. Bone Marrow Transplant. 1990 Nov;6(5):309-14. Bone Marrow Transplant. 1990. PMID: 1705459

7

Aggressive polychemotherapy for acute myelofibrosis.

Hertenstein B, Kurrle E, Frickhofen N, Heil G, Heimpel H. Hertenstein B, et al. Eur J Haematol. 1990 Apr;44(4):213-9. doi: 10.1111/j.1600-0609.1990.tb00382.x. Eur J Haematol. 1990. PMID: 2344883

8

Concentration of bone marrow mononuclear cells for in vitro treatment and AB0-incompatible transplantation: a rapid and reproducible procedure using the haemonetics V50 cell separator.

Wiesneth M, Hertenstein B, Koerner K, Heimpel H, Heit W. Wiesneth M, et al. Among authors: hertenstein b. Beitr Infusionsther. 1988;21:340-5. Beitr Infusionsther. 1988. PMID: 2463006

9

Evaluation of remission state in chronic myeloid leukemia patients after bone marrow transplantation using cytogenetic and molecular genetic approaches.

Arnold R, Bartram CR, Heinze B, Carbonell F, Wiesneth M, Hertenstein B, Schmeiser T, Heit W, Kubanek B, Heimpel H. Arnold R, et al. Among authors: hertenstein b. Bone Marrow Transplant. 1989 Jul;4(4):389-92. Bone Marrow Transplant. 1989. PMID: 2505880

10

Infectious complications after allogeneic bone marrow transplantation with and without T-cell depletion of donor marrow.

Schmeiser T, Wiesneth M, Bunjes D, Arnold R, Hertenstein B, Heit W, Kurrle E. Schmeiser T, et al. Among authors: hertenstein b. Infection. 1989 May-Jun;17(3):124-30. doi: 10.1007/BF01644010. Infection. 1989. PMID: 2661437

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

197 results

Search Page

Filters